29
© 2014 IBM Corporation 1 When ‘Go Mobile’ Goes Wrong: Top 9 Mistakes in Mobile Pharma Yonni Harif, Enterprise Mobility Executive, IBM

Mobile Pharma: When 'Go Mobile' Goes Wrong - Top 9 Mistakes

  • Upload
    yonster

  • View
    207

  • Download
    2

Embed Size (px)

DESCRIPTION

* Drawn from real-life examples, this session will explore strategy and technology pitfalls in mobile that pharma and life sciences companies must avoid * Scenarios will cover app development, design, governance and business strategy topics as they relate to both external and internal mobility initiatives

Citation preview

Page 1: Mobile Pharma: When 'Go Mobile' Goes Wrong - Top 9 Mistakes

© 2014 IBM Corporation1

When ‘Go Mobile’ Goes Wrong: Top 9 Mistakes in Mobile PharmaYonni Harif, Enterprise Mobility Executive, IBM

Page 2: Mobile Pharma: When 'Go Mobile' Goes Wrong - Top 9 Mistakes

© 2014 IBM Corporation2

There are 7.1 billion people on the planet6 billion of them have access to mobile phones, only 3.5 billion of them use a toothbrush

Page 3: Mobile Pharma: When 'Go Mobile' Goes Wrong - Top 9 Mistakes

© 2014 IBM Corporation3

Mobile Pharma App Use Cases

Patients+ Disease-specific (Diabetes, MS, Hemo, etc)+ Drug-specific (Flagship products, niche, etc)+ Self-diagnosis (GRACE for coronary, etc)+ Research (clinical trials, reports, etc)+ Wellness (schedules, exercise, nutrition, etc)+ Educational (tutorials, videos, etc)

Physicians/Clinics Research (reports, etc) Clinical trials (database, results, etc) Educational (tutorials, videos, etc) Disease-specific (Myeloma Resource, etc) Diagnosis (mobile imaging, etc)

Employees/Managers Sales force (mobile CRM, etc) Supply chain (floor-level, inventory mgmt, delivery, etc) HR / Financial (vacations, expenses, approvals, etc) Executive (KPIs, etc)

Page 4: Mobile Pharma: When 'Go Mobile' Goes Wrong - Top 9 Mistakes

© 2014 IBM Corporation4

Snapshot of Mobile Pharma

Page 5: Mobile Pharma: When 'Go Mobile' Goes Wrong - Top 9 Mistakes

© 2014 IBM Corporation5

Snapshot of Mobile Pharma

Page 6: Mobile Pharma: When 'Go Mobile' Goes Wrong - Top 9 Mistakes

© 2014 IBM Corporation6

Why Should You Care?

Number of Apps branded by Pharma / Life Sciences Companies in app stores’ Health & Wellness or Medical Top 100? Hint: count them on one hand

Most apps have No Ratings in the app stores Most searches in app stores for company names or branded

products deliver 3rd party apps All three major Pharma target audiences (patients, physicians,

employees) are active mobile users on smartphones and tablets Whole industries are shifting because of mobile (.e.g Uber…

Airbnb…etc)

What is your company doing in mobile?

Page 7: Mobile Pharma: When 'Go Mobile' Goes Wrong - Top 9 Mistakes

© 2014 IBM Corporation7 7

So, what are we doing wrong?

Page 8: Mobile Pharma: When 'Go Mobile' Goes Wrong - Top 9 Mistakes

© 2014 IBM Corporation8

1 Mobility is an Afterthought Extension of Online

Page 9: Mobile Pharma: When 'Go Mobile' Goes Wrong - Top 9 Mistakes

© 2014 IBM Corporation9

2 Patchwork Mobile Strategy and Disjointed Execution

Page 10: Mobile Pharma: When 'Go Mobile' Goes Wrong - Top 9 Mistakes

© 2014 IBM Corporation10

2 Patchwork Mobile Strategy and Disjointed Execution

Page 11: Mobile Pharma: When 'Go Mobile' Goes Wrong - Top 9 Mistakes

© 2014 IBM Corporation11

3 Prioritizing Users Away with OS / Device-specific Focus

L

Page 12: Mobile Pharma: When 'Go Mobile' Goes Wrong - Top 9 Mistakes

© 2014 IBM Corporation12

3 Prioritizing Users Away with OS / Device-specific Focus

Page 13: Mobile Pharma: When 'Go Mobile' Goes Wrong - Top 9 Mistakes

© 2014 IBM Corporation13

3 Prioritizing Users Away with OS / Device-specific Focus

Web-native continuumWeb-native continuum

• HTML5, JS, and CSS3 (full site or m.site)

• Quicker and cheaper way to mobile

• Sub-optimal experience

• HTML5, JS, and CSS

• Usually leverages Cordova

• Downloadable, app store presence, push capabilities

• Can use native APIs

• As previous• + more

responsive, available offline

• Web + native code

• Optimized user experience with native screens, controls, and navigation

• App fully adjusted to OS

• Some screens are multi-platform when makes sense

• App fully adjusted to OS

• Best attainable user experience

• Unique development effort per OS, costly to maintain

Hybrid

Pure web Pure native

Mobile web site

(browser

access)

Mobile web site

(browser

access)

Native shell

enclosing

external m.site

Native shell

enclosing

external m.site

Pre-packag

ed HTML5

resources

Pre-packag

ed HTML5

resources

HTML5 +

native UI

HTML5 +

native UI

Mostly native, some

HTML5 screens

Mostly native, some

HTML5 screens

Pure nativePure

native

Page 14: Mobile Pharma: When 'Go Mobile' Goes Wrong - Top 9 Mistakes

© 2014 IBM Corporation14

• Reading content on a mobile device is two times harder than reading on a PC.• Desktop screen: 39.18% comprehension score

• Mobile screen: 18.93% comprehension score

• Smaller screen decreases comprehension.

• Users must move around the page or between pages more, using scrolling to refer to other parts

of the content instead of simply glancing at the text. Scrolling introduces 3 problems: • It takes more time, thus degrading memory.

• It diverts attention from the problem at hand to the secondary task of locating the required part of the page.

• It introduces the new problem of reacquiring the previous location on the page.

A Book Apart’s experience. Coincidentally, they happen to be the publishers of one of the most popular books on responsive design

4 Designing Online Experiences for Mobile Screens

Page 15: Mobile Pharma: When 'Go Mobile' Goes Wrong - Top 9 Mistakes

© 2014 IBM Corporation15

4 Designing Online Experiences for Mobile Screens

Page 16: Mobile Pharma: When 'Go Mobile' Goes Wrong - Top 9 Mistakes

© 2014 IBM Corporation16

5 Looking at Mobile only through a Development Lens

z

OperationsOperations

Back-end

Front-end

30% of the value and effort is visible (mobile UI)

70%

of the value and effort lies under the surface

Short time to market

Web? Hybrid? Native?

Teamwork

Industrialize dev

Integrate with SDLC

Ensuring continued support in a quick-

changing landscape

Track problems that affect UX

Manage and enforce app

versions

SecuritySecurity

Dataprotection

Push upgrades

Appsecurity

Userauthentication

User engagementUser engagement

Connect to back-end

Efficient and flexible

push notifications

Offline availability

B2E app distribution

Track and leverage location

Page 17: Mobile Pharma: When 'Go Mobile' Goes Wrong - Top 9 Mistakes

© 2014 IBM Corporation17

6 Applying Online Security Tools to a Mobile Space

Page 18: Mobile Pharma: When 'Go Mobile' Goes Wrong - Top 9 Mistakes

© 2014 IBM Corporation18

6 Applying Online Security Tools to a Mobile Space

Security Intelligence

Enterprise Applicationsand Cloud Services

Identity, Fraud,and Data Protection

Content Security

Application Security

Transaction Security

Device Security

DATA

Personal and Consumer

Personal and Consumer Enterprise

Enterprise

Device Security Content Security Application Security Transaction Security

• Enroll, provision and configure devices, settings and mobile policy

• Fingerprint devices with a unique and persistent mobile device ID

• Remotely Locate, Lock and Wipe lost or stolen devices

• Enforce device security compliance: passcode, encryption, jailbreak / root detection

• Restrict copy, paste and share

• Integration with Connections, SharePoint, Box, Google Drive, Windows File Share

• Secure access to corporate mail, calendar and contacts

• Secure access to corporate intranet sites and network

Software Development Lifecycle

•Integrated Development Environment

•iOS / Android Static Scanning

Application Protection

•App Wrapping or SDK Container

•Hardening & Tamper ResistanceIBM Business Partner (Arxan)

•Run-time Risk DetectionMalware, Jailbreak / Root, Device ID, and Location

•Whitelist / Blacklist Applications

Access

•Mobile Access Management

•Identity Federation

•API Connectivity

Transactions

•Mobile Fraud Risk Detection

•Cross-channel Fraud Detection

•Browser Security / URL Filtering

•IP Velocity

•Mobile Malware

Security Intelligence

Advanced threat detection with greater visibility

Page 19: Mobile Pharma: When 'Go Mobile' Goes Wrong - Top 9 Mistakes

© 2014 IBM Corporation19

7 Mobile Governance Extremes - Helicopter vs. Free-range Parent

Who owns the mobile apps in the organization? Is IT mandating mobile development standards? Is there an established security standard for mobility? Do developers have full control over development cycle? Who owns the corporate app store certificates and deployment? How is app usage tracked and analyzed?

or

Page 20: Mobile Pharma: When 'Go Mobile' Goes Wrong - Top 9 Mistakes

© 2014 IBM Corporation20

8 Apps Abandoned and Forgotten

L

Page 21: Mobile Pharma: When 'Go Mobile' Goes Wrong - Top 9 Mistakes

© 2014 IBM Corporation21

8 Apps Abandoned and Forgotten

Page 22: Mobile Pharma: When 'Go Mobile' Goes Wrong - Top 9 Mistakes

© 2014 IBM Corporation22

8 Apps Abandoned and Forgotten

Page 23: Mobile Pharma: When 'Go Mobile' Goes Wrong - Top 9 Mistakes

© 2014 IBM Corporation23

8 Apps Abandoned and Forgotten

Page 24: Mobile Pharma: When 'Go Mobile' Goes Wrong - Top 9 Mistakes

© 2014 IBM Corporation24

9 Sitting on the Sidelines…

Page 25: Mobile Pharma: When 'Go Mobile' Goes Wrong - Top 9 Mistakes

© 2014 IBM Corporation25

Top 9 Mistakes in Mobile Pharma

1. Mobility is an Afterthought Extension of Online

2. Patchwork Mobile Strategy and Disjointed Execution

3. Prioritizing Users Away with OS / Device-specific Focus

4. Designing Online Experiences for Mobile Screens

5. Looking at Mobile only through a Development Lens

6. Applying Online Security Tools to a Mobile Space

7. Mobile Governance Extremes - Helicopter vs. Free-range Parent

8. Apps Abandoned and Forgotten

9. Sitting on the Sidelines…

Page 26: Mobile Pharma: When 'Go Mobile' Goes Wrong - Top 9 Mistakes

© 2014 IBM Corporation26

Page 27: Mobile Pharma: When 'Go Mobile' Goes Wrong - Top 9 Mistakes

© 2014 IBM Corporation27

© IBM Corporation 2014. All rights reserved. References in this document to IBM products or services do not imply that IBM intends to make them available in every country.

Trademarks of International Business Machines Corporation in the United States, other countries, or both can be found on the World Wide Web at http://www.ibm.com/legal/copytrade.shtml.

Let’s talk mobile.

Yonni Harif

Enterprise Mobility Executive

[email protected]

646-696-8213

Page 28: Mobile Pharma: When 'Go Mobile' Goes Wrong - Top 9 Mistakes

© 2014 IBM Corporation28

Page 29: Mobile Pharma: When 'Go Mobile' Goes Wrong - Top 9 Mistakes

© 2014 IBM Corporation29

Legal Disclaimer

• © IBM Corporation 2011. All Rights Reserved.• The information contained in this publication is provided for informational purposes only. While efforts were made to verify the completeness and accuracy of the information contained

in this publication, it is provided AS IS without warranty of any kind, express or implied. In addition, this information is based on IBM’s current product plans and strategy, which are subject to change by IBM without notice. IBM shall not be responsible for any damages arising out of the use of, or otherwise related to, this publication or any other materials. Nothing contained in this publication is intended to, nor shall have the effect of, creating any warranties or representations from IBM or its suppliers or licensors, or altering the terms and conditions of the applicable license agreement governing the use of IBM software.

• References in this presentation to IBM products, programs, or services do not imply that they will be available in all countries in which IBM operates. Product release dates and/or capabilities referenced in this presentation may change at any time at IBM’s sole discretion based on market opportunities or other factors, and are not intended to be a commitment to future product or feature availability in any way. Nothing contained in these materials is intended to, nor shall have the effect of, stating or implying that any activities undertaken by you will result in any specific sales, revenue growth or other results.

• If the text contains performance statistics or references to benchmarks, insert the following language; otherwise delete:Performance is based on measurements and projections using standard IBM benchmarks in a controlled environment. The actual throughput or performance that any user will experience will vary depending upon many factors, including considerations such as the amount of multiprogramming in the user's job stream, the I/O configuration, the storage configuration, and the workload processed. Therefore, no assurance can be given that an individual user will achieve results similar to those stated here.

• If the text includes any customer examples, please confirm we have prior written approval from such customer and insert the following language; otherwise delete:All customer examples described are presented as illustrations of how those customers have used IBM products and the results they may have achieved. Actual environmental costs and performance characteristics may vary by customer.

• Please review text for proper trademark attribution of IBM products. At first use, each product name must be the full name and include appropriate trademark symbols (e.g., IBM Lotus® Sametime® Unyte™). Subsequent references can drop “IBM” but should include the proper branding (e.g., Lotus Sametime Gateway, or WebSphere Application Server). Please refer to http://www.ibm.com/legal/copytrade.shtml for guidance on which trademarks require the ® or ™ symbol. Do not use abbreviations for IBM product names in your presentation. All product names must be used as adjectives rather than nouns. Please list all of the trademarks that you use in your presentation as follows; delete any not included in your presentation. IBM, the IBM logo, Lotus, Lotus Notes, Notes, Domino, Quickr, Sametime, WebSphere, UC2, PartnerWorld and Lotusphere are trademarks of International Business Machines Corporation in the United States, other countries, or both. Unyte is a trademark of WebDialogs, Inc., in the United States, other countries, or both.

• If you reference Adobe® in the text, please mark the first use and include the following; otherwise delete:Adobe, the Adobe logo, PostScript, and the PostScript logo are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States, and/or other countries.

• If you reference Java™ in the text, please mark the first use and include the following; otherwise delete:Java and all Java-based trademarks are trademarks of Sun Microsystems, Inc. in the United States, other countries, or both.

• If you reference Microsoft® and/or Windows® in the text, please mark the first use and include the following, as applicable; otherwise delete:Microsoft and Windows are trademarks of Microsoft Corporation in the United States, other countries, or both.

• If you reference Intel® and/or any of the following Intel products in the text, please mark the first use and include those that you use as follows; otherwise delete:Intel, Intel Centrino, Celeron, Intel Xeon, Intel SpeedStep, Itanium, and Pentium are trademarks or registered trademarks of Intel Corporation or its subsidiaries in the United States and other countries.

• If you reference UNIX® in the text, please mark the first use and include the following; otherwise delete:UNIX is a registered trademark of The Open Group in the United States and other countries.

• If you reference Linux® in your presentation, please mark the first use and include the following; otherwise delete:Linux is a registered trademark of Linus Torvalds in the United States, other countries, or both. Other company, product, or service names may be trademarks or service marks of others.

• If the text/graphics include screenshots, no actual IBM employee names may be used (even your own), if your screenshots include fictitious company names (e.g., Renovations, Zeta Bank, Acme) please update and insert the following; otherwise delete: All references to [insert fictitious company name] refer to a fictitious company and are used for illustration purposes only.